The per-protocol and intention-to-treat analyses as presented by the trial authors, where missing data were considered treatment failure, were more conservative and the result did not reach statistical significance.
← all excerpts
Artesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malaria.
1
—
—